Oxford

AstraZeneca gains $1.2 billion, poor countries to benefit in future

Nations are investing lots of money just to prevent the third wave. But, due to various issues like production issues, data disagreements, etc. vaccine is struggling to prove its credibility. Despite the issue of blood clotting, Vaccine has proved to be a huge success.

Over 40 lakh doses of Covid-19 vaccine administered on day 3 of Tika Utsav: Health Ministry

More than 10.85 crore COVID-19 vaccine doses have been administered across the country so far...

‘Aatmanirbharta’ named as Hindi word of the year 2020 by Oxford Languages

Oxford-AstraZeneca COVID-19 vaccine ‘Covishield’ probably to get nod by government today

Government planning to procure Oxford-AstraZeneca vaccine (COVID) on half the price from MRP

Oxford University COVID-19 Vaccine trials resume in the UK, India and Japan, but on hold in the US

AstraZeneca and Oxford University's experimental COVID-19 vaccine clinical trials have resumed in Japan. The trials were put on a hold due to the illness of a British volunteer. On September 6, a study participant felt ill with what was believed to be a rare spinal inflammatory disorder called transverse myelitis.

Oxford University and AstraZeneca’s Vaccine Trials Resume

Phase three trials for AstraZeneca’s coronavirus vaccine resume

After receiving a green signal from the United Kingdom’s Medicines Health Regulatory Authority that it was safe to resume clinical trials, AstraZeneca confirmed to resume. The company has declined to disclose medical information about the 'pause' of the trial.

New COVID-19 Vaccine from Oxford to begin human trials in partnership with Serum Institute of India

The U.K based company, SpyBiotech formed out of the University of Oxford in 2017 has devised a new COVID-19 vaccine on an experimental basis which has now begun human trials in Australia in partnership with the Serum Institute of India.